Elevated expression of eIF4E in confined early breast cancer lesions: Possible role of hypoxia
暂无分享,去创建一个
A. De Benedetti | Benjamin D. L. Li | A. De Benedetti | E. Turbat-Herrera | W. Anderson | R. Defatta | Robert J. DeFatta | William Anderson
[1] J. Vaidya,et al. Diseases of the breast , 2000, British Journal of Cancer.
[2] A. Harris,et al. Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. , 1998, British Journal of Cancer.
[3] A. Gingras,et al. The mRNA 5' cap-binding protein eIF4E and control of cell growth. , 1998, Current opinion in cell biology.
[4] T. Hasebe,et al. Significance of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptor Protein Expression in the Formation of Fibrotic Focus in Invasive Ductal Carcinoma of the Breast , 1997, Japanese journal of cancer research : Gann.
[5] Benjamin D. L. Li,et al. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas , 1997, Oncogene.
[6] A. De Benedetti,et al. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma , 1997, Cancer.
[7] M. Silverstein,et al. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. , 1997, Surgical oncology clinics of North America.
[8] A. Gingras,et al. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. , 1996, Oncogene.
[9] M. Polymenis,et al. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc , 1996, Molecular and cellular biology.
[10] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[11] A. De Benedetti,et al. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis , 1996, International journal of cancer.
[12] A. De Benedetti,et al. Overexpression of the proto‐oncogene/translation factor 4E in breast‐carcinoma cell lines , 1996, International journal of cancer.
[13] C. Kevil,et al. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. , 1995, Oncogene.
[14] G. Breier,et al. Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.
[15] A. De Benedetti,et al. The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas , 1995, International journal of cancer.
[16] I. Bièche,et al. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[17] B Fisher,et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.
[18] A. Patchefsky,et al. Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.
[19] B. Berse,et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.
[20] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[21] D. Wickerham,et al. Ductal carcinoma-in-situ. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Sonenberg. 8 mRNA 5′ Cap-binding Protein elF4E and Control of Cell Growth , 1996 .